surpass-cvot tirzepatide shows delivers comparable cardiovascular safety to dulaglutide in patients with type 2 diabetes and established ASCVD, reinforcing the shift toward therapies that optimize whole cardiometabolic systems. As outcome datasets grow Diabetes Distilled: SURPASS-CVOT – Tirzepatide

Norway: Similar to Sweden, with Regional Variations In Norway: Wegovy and Saxenda are both approved Public healthcare only covers the cost of these medicines for diabetes treatment

Ask your healthcare provider before taking Benadryl while nursing

Taking it right at bedtime, or worse, in the morning and expecting sleep benefits that same night, is not how the mechanism works

Shots generally offer higher bioavailability

Furthermore, no convincing evidence currently supports a direct association between gut microbiota composition and the risk of GLP-1 receptor agonist-associated pancreatitis

It seems that pharmacotherapy is starting to catch up with bariatric surgery with regards to initial weight loss, but long-term data are still not available